Marc Desjardins

Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B <i>Streptococcus</i> : Implications for Reporting Susceptibility Results

Marc Desjardins, Kiera L. Delgaty, K. Ramotar et al. · Journal of Clinical Microbiology · 2004 · 112 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Evaluation of the IDI-MRSA Assay for Detection of Methicillin-Resistant <i>Staphylococcus aureus</i> from Nasal and Rectal Specimens Pooled in a Selective Broth

Marc Desjardins, Christiane Guibord, B. Lalonde et al. · Journal of Clinical Microbiology · 2006 · 106 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series

Robert Slinger, Marc Desjardins, Anne McCarthy et al. · BMC Infectious Diseases · 2004 · 67 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study

George G. Zhanel, Heather J. Adam, Melanie Baxter et al. · Journal of Antimicrobial Chemotherapy · 2019 · 67 citations

Life Sciences, Infectious Diseases, Microbiology +17

Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection

M. Abraham, Marc Desjardins, L G Filion et al. · Infection and Immunity · 1996 · 56 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14